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Abstract
Background: Neuroinflammation is associated with many conditions that lead to dementia, such as
cerebrovascular disorders or Alzheimer’s disease. However, the specific role of neuroinflammation in the progression
of cognitive deficits remains unclear. To understand the molecular mechanisms underlying these events we used a
rodent model of focal cerebral stroke, which causes deficits in hippocampus-dependent cognitive function.
Methods: Cerebral stroke was induced by middle cerebral artery occlusion (MCAO). Hippocampus-dependent
cognitive function was evaluated by a contextual fear conditioning test. The glial neuroinflammatory responses
were investigated by immunohistochemical evaluation and diffusion tensor MRI (DTI). We used knockout mice for
P2Y1 (P2Y1KO), a glial ADP/ATP receptor that induces the release of proinflammatory cytokines, to examine the links
among P2Y1-mediated signaling, the neuroinflammatory response, and cognitive function.
Results: Declines in cognitive function and glial neuroinflammatory response were observed after MCAO in both
rats and mice. Changes in the hippocampal tissue were detected by DTI as the mean diffusivity (MD) value, which
corresponded with the cognitive decline at 4 days, 1 week, 3 weeks, and 2 months after MCAO. Interestingly, the
P2Y1KO mice with MCAO showed a decline in sensory-motor function, but not in cognition. Furthermore, the
P2Y1KO mice showed neither a hippocampal glial neuroinflammatory response (as assessed by
immunohistochemistry) nor a change in hippocampal MD value after MCAO. In addition, wild-type mice treated
with a P2Y1-specific antagonist immediately after reperfusion did not show cognitive decline.
Conclusion: Our findings indicate that glial P2Y1 receptors are involved in the hippocampal inflammatory response.
The findings from this study may contribute to the development of a therapeutic strategy for brain infarction,
targeting the P2Y1 receptor.
Keywords: Middle cerebral artery occlusion, Hippocampal neuroinflammation, Cognitive deficits,
Diffusion tensor MRI, P2Y1 receptor
Introduction
Defects in hippocampal function caused by the progression
of cerebrovascular disorders or Alzheimer’s disease can
lead to memory loss. Identifying the molecular mechanisms
underlying these cognitive deficits is a long-standing
goal in neuroscience. Recent studies suggest that
neuroinflammation may directly cause hippocampal
network dysfunction in the aging brain [1,2]. Although
neuroinflammation inducers, including beta-amyloid
protein, hypoxia, and oxidative stresses, are generated in
individual microenvironments [2], their effects converge
in the downstream molecular and cellular cascades that
transduce neuroinflammatory responses ( for example,
microgliosis or astrogliosis) [3]. A strong association
between such glial activation and changes in the hippo-
campal microenvironment, has been shown in mouse
models of cerebral ischemia and Alzheimer’s disease
[4,5]. The inflammatory responses generated by the
activated astrocytes disturb synaptic plasticity and may
cause a decline in cognitive function [6,7].
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The glial neuroinflammatory response is known to
involve the ADP/ATP receptor P2Y1, which is widely
distributed throughout the central nervous system (CNS).
The P2Y1 receptors are upregulated in glial cells in various
brain regions after ischemia [8]. Thus, P2Y1 on astrocytes
may transduce neuroinflammatory responses when
activated by ATP released from damaged neurons or glial
cells in various CNS disorders [9]. In addition, astrocytic
P2Y1 activation induces the release of proinflammatory
cytokines [10]. Thus, it is important to examine P2Y1’s
role under pathological conditions. Here we used P2Y1-
knockout (P2Y1KO) mice, which were recently reported
to resist vascular inflammation [11,12]. We subjected
the P2Y1KO mice to middle cerebral artery occlusion
(MCAO) to assess P2Y1’s role in initiating the neuro-
inflammatory response in the affected hippocampus
and the consequences of the neuroinflammation, including
cognitive deficits. The rodent MCAO model causes
both sensory-motor and cognitive deficits [13,14]. For
example, rats subjected to MCAO perform worse than
sham-operated rats in the Morris maze task [15]. Although
the neural atrophy caused by MCAO is primarily observed
in the striatum and cerebral cortex, previous studies have
reported conflicting results regarding the occurrence of
hippocampal damage following MCAO [13,15-18].
To monitor putative hippocampal microstructural changes
relating to the neuroinflammation caused by MCAO, we
applied a sensitive neuroimaging method, diffusion tensor
MRI (DTI) [19,20]. DTI can detect microscopic structural
changes that alter water diffusivity, such as the enlarge-
ment of glial cells upon their activation, in a region of
neuroinflammation [21,22]. This technique previously
revealed the magnitude of water diffusivity alteration
in the rat hippocampus after two-vessel occlusion [23]
and in the mouse hippocampus in an Alzheimer’s disease
model [24,25].
In this study, we focused on the hippocampal environ-
mental changes following the neuroinflammatory response
induced by MCAO. We examined glial activation by
immunohistochemistry and structural changes by DTI.
The aim of this study was to discover how an alteration
in the hippocampal microenvironment affects cogni-
tive function after MCAO. We also focused on the role
of the astrocytic P2Y1 receptor in regulating the neuro-
inflammatory response that affects cognitive function.
Material and methods
Animals
Adult male Sprague Dawley rats (280 to 300 g) and C57/
BL6 mice (18 to 25 g) were from Sankyo Labo Service
Corporation (Tokyo, Japan). The P2Y1KO (−/−) (C57/BL6
background) mice were generated previously [11]. All
animals were housed in individual cages with a 12-h
light/dark cycle and access to food and water ad libitum.
Experimental procedures were carried out in accordance
with animal experimentation protocols approved by the
Animal Care and Use Committee of the University of
Tokyo.
Surgery
Rats and mice were anesthetized intramuscularly with 100
mg/kg ketamine hydrochloride and 25 mg/kg xylazine.
Rectal temperature was monitored continuously by a
thermometer and heating pads (BWT-100, Bio Research
Center, Nagoya, Japan) were used to automatically maintain
body temperature at 37.0 to 37.5°C.
For rat MCAO, transient focal cerebral ischemia was
induced by a 90-min occlusion of the right middle cerebral
artery, as described previously [26]. In brief, a 4-0 nylon
monofilament (Nitcho Kogyo Co., Ltd., Tokyo, Japan) with
a silicon-coated tip was introduced into the right internal
carotid artery from the common carotid artery, and the
filament tip was kept in place for 90 min. The filament
was then withdrawn from the internal carotid artery to
allow reperfusion. After good spontaneous breathing was
confirmed, each animal was returned to its cage. For the
sham-operated rats, the common carotid artery and the
right external carotid artery were occluded.
For mouse MCAO, 8-0 nylon with an expanded (heated)
tip was introduced into the right internal carotid through
the external carotid stump, as described previously
[27]. The infarction time was 45 min. To evaluate the
infarcted area, serial coronal sections were obtained
from sites +3, +2, +1, +0, -1, -2, and −3 mm from the
bregma. The sections were stained with 0.5% cresyl violet
and scanned on both sides using a digital camera
(Camedia C-5050, Olympus Corporation, Tokyo, Japan).
For the continuous administration of MRS2500 (Tocris
Bioscience, Minneapolis, MN, USA) into mice, a micro-
osmotic pump (model 1007D, Alzet, Palo Alto, CA, USA)
filled with 100 μL MRS2500 (1 mg/mL), delivering 0.5 μL/
h, was implanted intracerebroventricularly immediately
after reperfusion using a Brain Infusion Kit 3 (Alzet, Palo
Alto, CA, USA).
Behavioral tests
To evaluate cognitive function, mice and rats were subjected
to fear conditioning 24 h before contextual and cued tests.
For conditioning, rats were placed individually in a condi-
tioning chamber (Med Associates, Inc., St Albans, Vermont,
USA) for 5 min; after 3 min they were given two tone/foot-
shock pairings. A 10-s tone (80 dB, 5 KHz) preceded a 2-s
foot-shock (0.75 mA) that co-terminated with the tone
(60-s interstimulus interval). Mice were placed in a box for
6 minutes and given three tone/foot-shock pairings (1 mA).
For both mice and rats, the chambers were inside a
sound-attenuating box equipped with a fan as white
noise, to minimize the effect of outside noise. The box
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was cleaned with 70% isopropanol before each use. For
contextual testing, freezing behavior was scored for 8 min
without any stimulation. For cued testing, the animals
were placed in a different context (red lighting, flat floor,
and curved wall) for 5 min following the contextual test.
After 3 min, a 10-s tone was delivered twice using the
same protocol as in the conditioning, without the shock.
The animals’ freezing behavior was scored for 3 min
before the tone (pre-tone) and for 2 min after the tone
was delivered (post-tone).
A 21-point behavioral scale [28] was used to evaluate
the sensory-motor function of rats after MCAO. Sham
and MCAO groups were prepared specifically for the
daily behavioral experiments (n = 6 each). However,
when mice were used for these tests, we could not
evaluate their standing ability on a 45-degree slope as
described by Hunter [28], because they weighed too little
for the test to be executed correctly.
Diffusion tensor imaging data acquisition
Following the behavioral tests, the rats were sacrificed at
three time points: 1 week, 3 weeks, and 2 months after
surgery (only at 1 week for sham-operated animals). They
were perfused with phosphate-buffered saline (PBS) intra-
cardially and decapitated. Each brain was post-fixed in 4%
formaldehyde (from paraformaldehyde) in PBS (pH 7.4) for
30 min at 4°C. The fixed brain was rinsed with PBS and
was then placed into the scanner within a plastic tube.
The magnetic resonance (MR) experiments on rats were
performed in a 4.7 T scanner (Varian Associates, Palo
Alto, CA) equipped with gradients of up to 60 mT/m. A
66-mm volume coil was used for both transmission and
reception. A 2D diffusion-weighted (DW) spin-echo se-
quence was used with the following acquisition parame-
ters: FOV = 30 × 30 mm2, image matrix = 128 × 128, slice
thickness/gap = 1/0 mm, TR/TE = 3000/50 ms, NEX = 40.
DW images were acquired in 12 directions with 2 b-values
of 0 and 1496 s/mm2. The total acquisition time was 55 h.
Mice were perfused intracardially with PBS, then with
4% formaldehyde in PBS (pH 7.4), and decapitated. Each
brain was post-fixed in 4% formaldehyde for at least 3
days at 4°C. The fixed brain was rinsed with PBS and
immersed in Fluorinert (Sigma Aldrich, St. Louis, MO,
USA) in a glass tube, because the MRI system is vertical.
The mouse MR experiments were performed in a 14.1 T
scanner (Bruker BioSpin, Billerica , MA, USA) equipped
with gradients of up to 3000 mT/m. A 10-mm volume
coil was used for both transmission and reception. A 2D
diffusion-weighted (DW) spin-echo sequence was used with
the following acquisition parameters: FOV = 6 × 6 mm2,
image matrix = 128 × 128, slice thickness/gap = 0.5/0 mm,
TR/TE = 2500/27 ms, NEX = 16. DW images were
acquired in 12 directions with 2 b-values of 0 and
1500 s/mm2. The total acquisition time was 19 h.
For the DTI of both rats and mice, motion-probing







































































Figure 1 Long-lasting cognitive decline after middle cerebral
artery occlusion (MCAO) in rats. Hippocampus-dependent
cognitive function was assessed by a contextual fear conditioning
test. The freezing time was measured for 8 minutes in MCAO and
sham-operated rats (A). Significant differences were seen at all the
time points between the MCAO and sham-operated group. Daily
neurological testing was conducted in a separate cohort for 4 weeks
(B). Most of the sensory motor function of the MCAO rats recovered
within the experimental period. n = 6 in each group. Values are
means ± SEM. *P <0.05; **P <0.01; in the t-test.
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Figure 2 Alteration in hippocampal mean diffusivity (MD) in middle cerebral artery occlusion (MCAO) rats visualized by MD map.
Diffusion-weighted anatomic images of the brains from the intact, sham, and 1-week, 3-weeks, and 2-months after MCAO groups (A). MD color
maps were created by MATLAB in the same slice for each group (B). Enlarged images of the boxed hippocampal areas of the sham and 1 week
after MCAO brains shown in B (C). The infarcted area shows an unusually high MD value in the ipsilateral side (left) of the brain. Meanwhile, the
white arrowhead indicates MD decreasing on the ipsilateral side of the hippocampus. MD values ranged from 0 to 5.0 × 10−4 (mm2/sec), as
shown in the color bar below. All slices were obtained at bregma -3.30 to -3.80 mm.
A B
C D
Figure 3 Region of interest (ROI)-based and voxel-based morphometric (VBM) analyses of the hippocampal mean diffusivity (MD) from
middle cerebral artery occlusion (MCAO) rats. The histological images were obtained from the rat brain atlas (A, [33]). Regions of interest (ROI)
for the hippocampal area were defined semi-automatically on diffusion-weighted images by ROI Editor (B: bregma -3.30 to -3.80 mm). The
hippocampal MD of the ipsilateral side was calculated for each group (C). All the post-MCAO groups showed a significant decrease. n = 6 for
each group. Values are means ± SEM. *P <0.05; **P <0.01 in the t-test versus intact group. #P <0.05; ###P <0.001 in the t-test versus sham-operated
group. T-contrast map showing a significant decrease in MD value was observed in the 1 week after MCAO group compared to the intact group
(D: uncorrected, P <0.001). The ipsilateral hippocampus and striatum areas showed significant differences. For the groups tested at 3 weeks and 2
months after MCAO, the realignment process could not be performed by the software, because the chronic MCAO brains were too greatly
altered. Color bars, t value (Height threshold t = 4.025).
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These sample preparation and DTI data acquisition
methods were based on previous research with minor
modifications [19,29].
Image and data analysis
The six independent elements of the 3 × 3 diffusion
tensor were calculated from each series of DW images.
The tensor was diagonalized to obtain three eigenvalues
(λ1-3), which corresponded to the three eigenvectors (ν1-3).
The DTI index Trace(D), which is a scalar measurement
of the total diffusion within a voxel, was derived from the
DTI-studio software [30].
Trace Dð Þ ¼ λ1 þ λ2 þ λ3
The mean diffusivity (MD) is a measure of the average
motion of water molecules independent of directionality,
which was obtained from the Trace(D). For the color-
coded MD maps, MATLAB (Math Works, Natick, MA,
USA) was used. The MD value range was defined as 0 to
5.0 × 10−4 mm2/sec.
MD ¼ λ1 þ λ2 þ λ3
3
¼ Trace Dð Þ
3
Regions of interest (ROIs) were semi-automatically
defined in the images generated from DTI Studio, by
ROI Editor [30].
To make the T-contrast map, SPM5 software (Welcome
Trust Center for Neuroimaging, England, UK) running on
MATLAB, was used for slice realignment and spatial
normalization of the DTI data [31]. We analyzed the areas
that showed a significant decrease in MD (P <0.001,
uncorrected) at 1 week after MCAO (n = 6), compared





Figure 4 Hippocampal neuroinflammatory gliosis after middle cerebral artery occlusion (MCAO) in rats. Representative comparisons
between 1 week post-MCAO and sham-operated rats (A,C). Slices from each region of the hippocampus (dentate gyrus (DG)/hilus, CA2/3, and
CA1) were stained with anti-GFAP and anti-Iba1 antibodies and scanned. The proportion (area ratio) of GFAP (B) and Iba1 (D) staining was
calculated for each region. n = 4 in each group. Red, GFAP; Green, Iba1; Blue, DAPI. Bar represents 100 μm. Values are means ± SEM. *P <0.05;
**P <0.01 in the t-test.
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Immunohistochemical analysis
For fluorescence immunohistochemistry, frozen specimens
were coronally sectioned with a cryostat (Microm) at a
thickness of 40 μm. After being blocked in 3% donkey
serum, the sections were incubated with anti-glial fibrillary
acidic protein (GFAP; mouse, 1:800; Sigma Aldrich, St.
Louis, MO) and anti-ionized calcium binding adaptor
molecule 1 antibodies (Iba1; rabbit, 1:1000; Wako)
overnight at 4°C. The secondary antibodies were Alexa
488-conjugated donkey anti-rabbit IgG (1:1,000; Molecular
Probes) and Cy5-conjugated donkey anti-mouse IgG (1:200;
Jackson ImmunoResearch Laboratories, Inc., West Grove,
PA, USA). The stained sections were incubated with DAPI
(Sigma Aldrich), and observed using a confocal laser
microscope (TCS SP2; Leica Microsystems, Wetzlar,
Germany). Images obtained via confocal microscopy
were analyzed with ImageJ software, as reported in our
previous study [32]. A custom plugin was used to auto-
matically establish the overall fluorescence from the image
(> 0.28 mm2) at the dentate gyrus (DG)/hilus, the CA2
and CA3 (CA2/3) regions, or the CA1 region, and to
calculate the percentage of the image covered by staining.
Statistical analysis
The data are shown as the mean ± SEM. Statistical
significance was determined using Student’s t-test and
Tukey’s multiple comparison test. P <0.05 indicated
statistically significant differences.
Results
Long-lasting deficit in cognitive function after middle
cerebral artery occlusion in rats
We tested the cognitive function of rats 1 week, 3 weeks,
and 2 months after MCAO, and observed a clear decrease
in the freezing time in the contextual conditioned test at
all the time points tested, compared to the control rats 1
week after the sham operation (n = 6 in each group;
P <0.05, Figure 1A). In contrast, in a cue test, we did
not observe a significant difference in the freezing behavior
among the groups (data not shown).
We also evaluated the time course of sensory-motor
function after MCAO. A sensory-motor neurological test
was conducted in a different cohort of MCAO and
sham-operated rats (n = 6 in each group) every day
from 1 to 28 days after the operation. As shown in
Figure 1B, we detected significant recovery in the
sensory-motor function of the MCAO rats, suggesting
the regeneration and/or functional repair of the damaged
neural networks. Taken together, these findings indicated
that over the long term after MCAO, the occurrence of
cognitive deficits was still a concern, despite sensory-
motor recovery.
Long-lasting hippocampal changes after middle cerebral
artery occlusion in rats detected by diffusion tensor
imaging
For the sensitive detection of microstructural alterations
in the hippocampus of MCAO rats, we performed ex-vivo
DTI analyses. The brain was fixed with 4% formaldehyde
for 30 min at 4°C, by a slight modification of the method
described by Shepherd [17]. The post-fixed brain was
placed in a plastic tube without any solution and scanned
in a 4.7-T animal magnetic resonance imaging (MRI)
with 12-axis multi-slice DTI for 55 hours. We analyzed
the change in the affected hippocampus by determining
the mean diffusivity (MD) value, a type of DTI index.
Examples of coronal color images of the MD values in
Figure 2 show the brain from a normal non-operated rat
as an intact control, the brain from a sham-operated rat
1 week after surgery as an internal control, and the
brains of MCAO-treated rats 1 week, 3 weeks, and 2
A
B
Figure 5 Cognitive function was retained in P2Y1KO mice after
middle cerebral artery occlusion (MCAO). Contextual fear
conditioning (A) and neurological (B) tests similar to the
experiments with rats were performed. Both of the tests were
conducted 1 week after MCAO. P2Y1KO mice retained their
hippocampus-dependent cognitive function, while they showed
sensory motor deficits similar to WT mice. WT-sham, n = 18;
WT-MCAO, n = 19; P2Y1KO-sham, n = 14; P2Y1KO-MCAO, n = 14.
Values are means ± SEM. **P <0.01, ***P <0.001 in Tukey’s multiple
comparison test.
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months after surgery. A detailed visual inspection revealed
a clear decrease in the MD value at the CA2/3 pyramidal
cell layer of the ipsilateral hippocampus (indicated by an
arrowhead in Figure 2C).
Next, we quantitatively analyzed the change in the MD
value at the affected hippocampus. For this analysis, we
used DTI Studio for the MD calculation, with semi-
automatic morphometric identification of the hippocam-
pus by ROI Editor. We detected a significant reduction in
the MD value of the ipsilateral hippocampus (P <0.05)
after MCAO, compared to the intact or sham group
(Figure 3C). The contralateral hippocampus did not
show a significant MD decrease after MCAO (data
not shown). For a more precise verification of the
decreased MD value, we performed a voxel-based
morphometric (VBM) analysis, as a fully automatic digital
comparison of imaging data between the MCAO and
sham-operated rats. The T-contrast map image revealed a
significant reduction in the MD value after MCAO
(Figure 3D).
Hippocampal neuroinflammation after middle cerebral
artery occlusion in rats
To evaluate the neuroinflammation-related cellular changes
in the ipsilateral hippocampus after MCAO, we stained
brain sections with anti-GFAP (a marker for activated
astrocytes) and anti-Iba1 (a marker for activated microglia).
As shown in Figure 4, separate subregions of the hippo-
campus were scanned (DG/hilus, CA2/3, and CA1).
Increased activation of both astrocytes and microglia
was observed in the CA2/3 region (Figure 4B, D),
suggesting that neuroinflammatory responses were evoked
in the hippocampus by MCAO. These alterations were
also observed in the hippocampal slices 3 weeks and 2





Figure 6 Lack of hippocampal neuroinflammation in P2Y1KO mice. Representative comparisons between WT-MCAO and P2Y1KO-MCAO
mice 1 week after surgery (A,C). Slices showing each region of the hippocampus (DG/hilus, CA2/3, and CA1) were stained with anti-GFAP and
anti-Iba1 antibodies and scanned. The proportion (area ratio) of GFAP (B) and Iba1 (D) staining was calculated for each region. In KO mice, the
GFAP expression was suppressed significantly in CA2/3, whereas Iba1 was significantly decreased in all hippocampal areas. Red, GFAP; green, Iba1;
blue, DAPI. n = 4 in each group. Values are means ± SEM. *P <0.05; **P <0.01 in the t-test. Magnification = 40×; scale bar, 100 μm.
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Disappearance of the cognitive deficit and hippocampal
neuroinflammation after middle cerebral artery occlusion
in P2Y1KO mice
To examine the molecular basis of the cognitive deficits
subsequent to MCAO, we used P2Y1KO mice and
wild-type (WT) C57BL/6 mice. We prepared four
groups of mice: WT-sham, WT-MCAO, P2Y1KO-sham,
and P2Y1KO-MCAO. We first measured the cognitive
and sensory-motor function 1 week after MCAO. In the
contextual conditioning test, the WT mice showed cogni-
tive deficits, as seen in rats. However, the P2Y1KO mice
exhibited no decline in cognitive function after MCAO
(Figure 5A). The P2Y1KO-sham mice exhibited cognitive
function equivalent to that in WT-sham mice. The
sensory-motor function was equally impaired in the
WT-MCAO and P2Y1KO-MCAO mice (Figure 5B). The
size of the infarction at the neocortex and the striatum as
evaluated by Nissl staining was also equivalent between
the two groups (WT: 13.6 ± 1.37%; KO: 12.1 ± 1.70% of
the total brain).
We stained mouse brain sections in the same manner
as in the study of rats. Images from the ipsilateral hippo-
campus of the WT-MCAO and P2Y1KO-MCAO groups
were evaluated (Figure 6). In the P2Y1KO mice, the
activation of astrocytes was decreased in the CA2/3 region
(Figure 6B), and significantly fewer activated microglia
were seen in all the regions (Figure 6D) compared with
wild-type mice, suggesting that the neuroinflammatory
responses were suppressed in the hippocampus of the
P2Y1KO mice. We also checked the background glial-
activation level in the sham-operated P2Y1KO mice,
and found no difference between the KO-sham and
WT-sham groups (data not shown).
P2Y1’s involvement in the cognitive decline after middle
cerebral artery occlusion in mice
To examine the involvement of P2Y1-mediated signaling
in the course of the cognitive decline induced by a focal
cerebral ischemia, MCAO, we examined whether cognitive
decline occurred 3 to 4 days after the operation, during a
more acute phase of the ischemic injury. We chose this
time point because P2Y1-dependent neural stem cell
proliferation was not pronounced at 3 days, compared
to 1 week after MCAO (data not shown); therefore, the
putative P2Y1-dependent cognitive decline might not










Figure 7 Cognitive function in the acute phase and effect of blocking P2Y1. A contextual fear conditioning test was conducted 4 days after
middle cerebral artery occlusion (MCAO). The results were similar to those of the 1 week after MCAO group. The P2Y1 receptor antagonist
MRS2500 led to remarkably maintained cognitive function. MRS2500 was administered by pump, starting immediately after the 45-min MCAO.
WT-sham, n = 7; WT-MCAO, n = 10; WT-MCAO-MRS2500, n = 5; P2Y1KO-sham, n = 9; P2Y1KO-MCAO, n = 8. Values are means ± SEM. **P <0.01, in
Tukey’s multiple comparison test.
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For this experiment, we utilized a P2Y1-specific antagon-
ist MRS2500 and prepared five groups of mice: WT-sham,
WT-MCAO, WT-MCAO-MRS2500, P2Y1KO-sham, and
P2Y1KO-MCAO. Contrary to our initial speculation, in
the contextual conditioning tested 4 days after injury, the
WT-MCAO mice showed significant cognitive deficits
compared to the WT-sham mice. Interestingly, WT-MCAO
mice treated with the P2Y1 antagonist MRS2500 by
osmotic pump soon after reperfusion, did not show
any cognitive decline. In addition, the P2Y1KO-MCAO
mice exhibited cognitive function equivalent to that of the
WT-sham and P2Y1KO-sham mice (Figure 7). Taken
together, these findings suggest that P2Y1-mediated
signaling from the time of reperfusion to 4 days after
MCAO contributes to the MCAO-induced cognitive
decline in mice.
P2Y1’s involvement in the decreased hippocampal mean
diffusivity value after middle cerebral artery occlusion
in mice
We next performed an ex-vivo DTI analysis using the
brains of mice that had been used for the behavioral test
shown in Figure 7. Within a day after the behavior test,
the brains were fixed with 4% formaldehyde for at least
3 days at 4°C. The post-fixed brains were placed into
10-mm NMR tubes and scanned in a 14.1-T animal MRI
with 12-axis multi-slice DTI for 19 hours. We analyzed
the change in the affected hippocampus by determining the
MD value after DTI. We detected a significant reduction
in the MD value of the ipsilateral hippocampus (P <0.05)
of the WT-MCAO mice compared to the WT-sham mice
(Figure 8). In contrast, the P2Y1KO-MCAO brains showed
a hippocampal MD value equivalent to that of the WT-
sham and P2Y1-sham brains. A detailed visual inspection
revealed a clear decrease in the MD value at the CA2/3
pyramidal cell layer of the ipsilateral hippocampus of the
WT-MCAO brains, compared to that of the P2Y1KO-
MCAO brains (indicated by arrowheads in Figure 8D, E).
Discussion
The cognitive impairment that occurs after cerebral ische-
mia, especially in memory function, has recently attracted
much attention [14-16,34,35]. In animal studies, MCAO
disturbs cognitive function as detected by a water maze test
[14,15] or a contextual conditioning test (this study). How-
ever, to our knowledge, there are few reports monitoring
the chronic pathological or histological alterations in the
hippocampus after MCAO. In this study, we observed im-
paired cognitive function, hippocampal neuroinflammation,
and microstructural changes in MCAO model rats and
mice. To examine the underlying mechanism affecting
cognitive function, we focused on the ADP/ATP receptor
P2Y1 expressed on activated glial cells. Our findings
clearly indicated that P2Y1-dependent neuroinflammation
contributes to the pathophysiological mechanism of the
functional alteration in the hippocampus.
In this study, we successfully depicted stroke-related
hippocampal microstructural alterations by an MRI method,
diffusion tensor MRI (DTI). DTI has been used to detect
tissue abnormalities in a variety of diseases [36-39].










Figure 8 No decrease in hippocampal mean diffusivity (MD) value
after middle cerebral artery occlusion (MCAO) in P2Y1KO-MCAO
mice. Ex-vivo T2-weighted (A) and diffusion-weighted (B) images of
the ipsilateral hemisphere. Regions of interest ( ROIs) for the
hippocampal area were defined semi-automatically using ROI Editor
(B). The MD value of the ipsilateral side of the brain from four groups
was calculated (C). WT-sham, n = 4; WT-MCAO, n = 4; P2Y1KO-sham,
n = 4; P2Y1KO-MCAO, n = 4. Values are means ± SEM. *P <0.05,
**P <0.01, in Tukey’s multiple comparison test. Representative
hippocampal MD maps from WT-MCAO (D) and P2Y1KO-MCAO
(E) mice. MD maps were depicted by MATLAB. White arrowheads
indicate the different MD values between the two groups at the
ipsilateral side of the hippocampus. MD values ranged from 0 to
5.0 × 10−4 (mm2/sec), shown in the bar at right. All slices were
obtained at bregma -1.80 to -2.30 mm.
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Ex-vivo DTI has several advantages over in-vivo DTI,
including better signal-to-noise ratio, improved spatial
resolution, and fewer motion artifacts [19]. Ex-vivo DTI is
suitable for animal studies, in which tissue can be re-
moved for detailed evaluation, and may be superior to
conventional T2-weighted imaging or immunohistochem-
ical methods. Our results showed that MCAO caused a
significant reduction in the hippocampal MD, which
may indicate microstructural tissue changes owing to
cell swelling or hypertrophy [36]. We assume that the
stroke-related enlargement of activated astrocytes or
microglial cells contributes to this putative structural
change after MCAO. However, the hippocampal MD
value did not recover, which would be related to the
long-term deficit (2 months after MCAO) in cognitive
function. In both ROI-based analyses using DTI Studio
[30] and group-based analyses using SPM [31], a significant
MD change between the MCAO and sham-operated
animals was observed. However, we did not find a
significant change in fractional anisotropy value, in
contrast to a previous study [39].
It is reasonable to assume that the reduction in
MD value we observed is related to the augmented
neuroinflammatory response. We detected a significant
elevation of the neuroinflammatory response in the CA2/
3 region of the hippocampus by anti-GFAP and anti-Iba1
immunohistochemistry, and this region also showed the
most significant reduction in MD value in both the MD
color maps and the T-contrast map. Concurrently, we
carefully examined the integrity of the CA1 pyramidal cell
layer, which is the most vulnerable area in the hippocam-
pus [40], but did not detect hippocampal neuronal death
in our model (data not shown).
Our study opens the possibility that P2Y1-dependent
inflammatory responses are associated with cognitive
deficit. Recent studies have shown that ischemia in-
creases the extracellular ATP released by damaged cells,
which stimulates astrocytic P2Y1, resulting in high GFAP
expression [10,41]. Given that GFAP upregulation occurs
12 h after reperfusion [42], we also evaluated the cognitive
function at a more acute phase (3 to 4 days), and adminis-
tered a P2Y1 antagonist, MRS2500, soon after the reperfu-
sion. Our findings clearly showed that P2Y1signaling has a
critical role from the time right after reperfusion through
the next 4 days. During these days, it can be supposed
that microglia initially reacts to ischemic damage and
releases small amount of ATP which augment the P2Y1-
mediated signaling on astrocytes, as reported by Pascual
et al. [43]. Although activated astrocytes sometimes
provide beneficial effects by producing cytokines that
support cell regrowth [29,44], these cytokines, such as
TNF-α, interleukin-6, or interleukin1-β, may also
disturb synaptic plasticity, such as in LTP and cognitive
function [6,7,10,45-47].
In line with this scenario, we clearly demonstrated that
the blockade of P2Y1-mediated signaling, by either P2Y1KO
mice or a P2Y1-specific antagonist, ameliorated the
cognitive deficits induced by a focal cerebral stroke,
MCAO. Very recently, Choo et al. reported that the
antagonism of P2Y1 reduces hippocampal neuronal death
and cognitive deficit after traumatic brain injury [48]. Data
from our study suggest that the signaling through P2Y1
receptors on glial cells contributes to hippocampal
neuroinflammation and cognitive deficit, and these
findings may lead to new therapeutic strategies for brain
infarction, targeting the P2Y1 receptor.
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